CONCORDBIO - IntraDay Trade Analysis with Live Signals
Last Updated Time : 20 Dec 25, 07:02 am
Back to IntraDay Trade ListIntraDay Trade Rating: 3.2
| Stock Code | CONCORDBIO | Market Cap | 14,029 Cr. | Current Price | 1,341 ₹ | High / Low | 2,452 ₹ |
| Stock P/E | 43.6 | Book Value | 174 ₹ | Dividend Yield | 0.80 % | ROCE | 28.4 % |
| ROE | 21.4 % | Face Value | 1.00 ₹ | DMA 50 | 1,455 ₹ | DMA 200 | 1,625 ₹ |
| Chg in FII Hold | -1.07 % | Chg in DII Hold | 0.70 % | PAT Qtr | 62.9 Cr. | PAT Prev Qtr | 42.6 Cr. |
| RSI | 36.9 | MACD | -30.9 | Volume | 56,452 | Avg Vol 1Wk | 1,24,026 |
| Low price | 1,315 ₹ | High price | 2,452 ₹ | PEG Ratio | 1.63 | Debt to equity | 0.00 |
| 52w Index | 2.30 % | Qtr Profit Var | -36.3 % | EPS | 30.7 ₹ | Industry PE | 30.6 |
📊 Analysis: CONCORDBIO is trading at 1,341 ₹, well below both 50 DMA (1,455 ₹) and 200 DMA (1,625 ₹), reflecting short-term weakness. RSI at 36.9 indicates oversold-to-weak momentum, while MACD (-30.9) signals bearish undertone. Volume (56,452) is significantly below average (1,24,026), showing weak intraday participation. Fundamentals remain strong with debt-free balance sheet, high ROCE and ROE, but profit decline and weak momentum indicators suggest caution for intraday trades.
💡 Optimal Buy Price: 1,330–1,345 ₹ if price stabilizes near support.
🎯 Profit-taking Exit Levels: 1,360 ₹ (first resistance), 1,380 ₹ (next resistance).
🛡️ Stop-loss / Loss Protection: 1,320 ₹ (below intraday support).
⏱️ If Already Holding: Exit if price fails to hold above 1,330 ₹ or RSI drops below 35 with declining volume. Momentum exit can be triggered near 1,360–1,370 ₹ if upward move lacks strength.
Positive
- ✅ Strong ROCE at 28.4% and ROE at 21.4%.
- ✅ EPS at 30.7 ₹ supports valuation strength.
- ✅ Debt-free balance sheet (Debt-to-equity: 0.00).
- ✅ DII holding increased (+0.70%).
Limitation
- ⚠️ Current price below both 50 DMA and 200 DMA.
- ⚠️ RSI at 36.9 reflects weak momentum.
- ⚠️ MACD (-30.9) indicates bearish undertone.
- ⚠️ Volume significantly below average, showing weak intraday participation.
- ⚠️ High P/E of 43.6 compared to industry average (30.6).
Company Negative News
- 📉 Quarterly PAT decline (62.9 Cr. vs 42.6 Cr. previous, but overall negative variation).
- 📉 Quarterly profit variation negative (-36.3%).
- 📉 FII holding reduced (-1.07%).
Company Positive News
- 📈 DII holding increased (+0.70%).
- 📈 EPS at 30.7 ₹ reflects earnings strength despite short-term weakness.
Industry
- 🏭 Industry P/E at 30.6, lower than company’s 43.6, showing premium valuation.
- 🏭 52-week index return at 2.30%, indicating weak sector momentum.
Conclusion
📌 CONCORDBIO is a weak intraday candidate with limited upside. Buy near 1,330–1,345 ₹ with stop-loss at 1,320 ₹. Exit around 1,360–1,380 ₹ if momentum sustains. Strong fundamentals support long-term view, but weak RSI, MACD, and low volume suggest intraday trades should be closely monitored.
Would you like me to extend this into a peer benchmarking overlay so you can compare CONCORDBIO against other pharma and biotech sector stocks for intraday confirmation?
Back to IntraDay Trade ListNIFTY 50 - Today Top Intraday Trade Stock Picks
NEXT 50 - Today Top Intraday Trade Stock Picks
MIDCAP - Today Top Intraday Trade Stock Picks
SMALLCAP - Today Top Intraday Trade Stock Picks